Group sales increased by EUR 17.3 mill. up to EUR 555.3 mill.; preliminary Group operating result amounts to EUR 23.6 mill.

Offenburg, February 19, 2016 - MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 555.3 mill. in the FY 2015. The sales plus was EUR 17.3 mill. or 3.2% against previous year. The preliminary Group operating result (Group-EBIT) increased from EUR 15.6 mill. to EUR 23.6 mill. and the preliminary result attributable to shareholders of MediClin AG from EUR 8.5 mill. to EUR 16.5 mill. Earnings per share account to EUR 0.35 (previous year: EUR 0.18).

The largest share of sales growth posted the post-acute segment with EUR 16.5 mill. Especially the clinics contributed to this development which offer additional medical services of acute-neurology and acute-psychosomatic in the scope of an integrated care concept. The segment achieved sales of EUR 330.9 mill. (previous year: EUR 314.4 mill.) The nursing care business area accounted for EUR 14.1 mill. contributing EUR 1.0 mill. to sales growth. Sales of the acute segment amounted to EUR 206.7 mill., thus being EUR 0.6 mill. below previous years value, because only eight medical care centres added to sales growth instead of ten as in the previous year. Without the sales decrease of the medical care centres sales in the acute segment would be up by EUR 0.7 mill. The segment results of the post-acute and acute segment increased by EUR 4.0 mill. respectively EUR 0.5 mill. against previous year. In the post-acute segment higher staff costs could be more than compensated by significantly higher sales and lower material costs compared to the previous year. In the acute segment lower material costs and staff costs led to an increase of result despite a slight decrease in sales.

In the FY 2015 about EUR 27.0 mill. (previous year: EUR 21,0 mill.) were invested in capital expenditure including EUR 2.7 mill. (previous year: EUR 4.4 mill.) subsidies. As of December 31, 2015 cash and cash equivalents amounted to EUR 29.5 mill. (31.12.2014: EUR 26.3 mill.); the equity ratio was 51.3% (31.12.2014: 48.2%).

The press conference and the analysts and investors conference will take place in Frankfurt on March 23, 2015. From that date onwards the annual report 2015 will be available under www.mediclin.de in German and English.